The impact of sarcopenia on prognosis and fruquintinib efficacy in advanced colorectal cancer: a retrospective and mendelian randomization study
Sarcopenia could be a prognostic factor in patients with advanced CRC receiving fruquintinib targeted therapy.
Authors
- Tingting Zhu (ORCID: https://orcid.org/0000-0001-5512-3372)
- Song Gao
- Yufei Tang (ORCID: https://orcid.org/0000-0001-6281-9757)
- Chao Wang (ORCID: https://orcid.org/0000-0001-5535-3557)
- Yao Wang (ORCID: https://orcid.org/0000-0002-9352-422X)
- Fenggang Hou (ORCID: https://orcid.org/0000-0003-1791-3968)
- Xiaoling Yin
- Qi Shi (ORCID: https://orcid.org/0000-0003-4727-1337)
- Du Meilu
- Han Susu
- Wen Haotian
Institutions
- Ruijin Hospital (CN)
- Shanghai Traditional Chinese Medicine Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-07-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1582308
- Citations
- 1
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China